New Biotic
RaphaLX™ Trial Process News Get Updates More info
New Biotic ALS
RaphaLX™Trial ProcessNews About New Biotic ALS Get UpdatesMore info
New Biotic

Pilot Study

July 31, 2017. A pilot study on a cohort of 16 ALS patients was initiated. New Biotic, Inc. has a collaboration agreement with the Avera Institute for Human Genetics and the Avera Health System which serve ALS patients throughout SD, portions of MN, IA and NE.

New BioticJuly 31, 2017
Facebook0 Twitter LinkedIn0 Reddit Tumblr Pinterest0 0 Likes
Previous

Patents Filed

New BioticDecember 15, 2017
Next

Orphan Drug Designation from the FDA for RaphaLX™

Never SettleJanuary 3, 2017
 

If You Are Interested In Learning More About THE RaphaLX™ CLINICAL TRIAL, Sign Up To Receive Updates.

Sign Up

Biotherapeutics For Neurological Disorders

NEW BIOTIC
ABOUT
INVESTING
CAREERS
CONTACT

RAPHALX™
ABOUT
TRIAL PROCESS
FAQ

PIPELINE
NEWS
DISCLAIMER
PRIVACY POLICY

NEW BIOTIC, INC.

17875 VON KARMAN AVE., STE 150
IRVINE, CA 92614, USA
TEL: +1-949-556-8739
FAX: +1-949-556-8701
ENQUIRIES@NEWBIOTIC.COM

Copyright 2022 | New Biotic, Inc. | All Rights Reserved | Design By

Gray Never Settle.png